Peer-reviewed Artikel
Brief Bioinform. 2022 Nov 19;23(6):bbac433. doi: 10.1093/bib/bbac433.
Melanoma 2.0. Skin cancer as a paradigm for emerging diagnostic technologies, computational modelling and artificial intelligence
Vera J, Lai X, Baur A, Erdmann M, Gupta S, Guttà C, Heinzerling L, Heppt MV, Kazmierczak PM, Kunz M, Lischer C, Pützer BM, Rehm M, Ostalecki C, Retzlaff J, Witt S, Wolkenhauer O, Berking C Cell Mol Life Sci. 2022 Apr 9;79(5):229. doi: 10.1007/s00018-022-04264-8.
Novel integrated workflow allows production and in-depth quality assessment of multifactorial reprogrammed skeletal muscle cells from human stem cells.
Faustino D, Brinkmeier H, Logotheti S, Jonitz-Heincke A, Yilmaz H, Takan I, Peters K, Bader R, Lang H, Pavlopoulou A, Pützer BM, Spitschak A Front Cell Dev Biol. 2022 Feb 3;10:842596. doi: 10.3389/fcell.2022.842596. eCollection 2022.
Editorial: Multidisciplinary Approaches in Exploring Cancer Heterogeneity, TME and Therapy Resistance: Perspectives for Systems Medicine
Pützer BM, Sabapathy KFront Cell Dev Biol. 2021 Sep 28;9:737735. doi: 10.3389/fcell.2021.737735.
Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond
Logotheti S, Richter C, Murr N, Spitschak A, Marquardt S, Pützer BMInt J Mol Sci. 2021 Sep 5;22(17):9601. doi: 10.3390/ijms22179601.
In Silico Methods for the Identification of Diagnostic and Favorable Prognostic Markers in Acute Myeloid Leukemia
Yılmaz H, Toy HI, Marquardt S, Karakülah G, Küçük C, Kontou PI, Logotheti S, Pavlopoulou AFront Cell Dev Biol. 2021 Jun 2;9:682619. doi: 10.3389/fcell.2021.682619. eCollection 2021.
A Systems-Based Key Innovation-Driven Approach Infers Co-option of Jaw Developmental Programs During Cancer Progression
Marquardt S, Pavlopoulou A, Takan I, Dhar P, Pützer BM, Logotheti SCancers (Basel) . 2020 Dec 16;12(12):3789. doi: 10.3390/cancers12123789.
Neural Networks Recapitulation by Cancer Cells Promotes Disease Progression: A Novel Role of p73 Isoforms in Cancer-Neuronal Crosstalk
Logotheti S, Marquardt S, Richter C, Hain RS, Murr N, Takan I, Pavlopoulou A, Pützer BMTheranostics. 2020 Jul 29;10(21):9620-9643. doi: 10.7150/thno.44176. eCollection 2020.
LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1
Logotheti S, Marquardt S, Gupta SK, Richter C, Edelhäuser BAH, Engelmann D, Brenmoehl J, Söhnchen C, Murr N, Alpers M, Singh KP, Wolkenhauer O, Heckl D, Spitschak A, Pützer BMCancers (Basel). 2020 Apr 3;12(4):876. doi: 10.3390/cancers12040876.
MiRNAs Targeting Double Strand DNA Repair Pathways Lurk in Genomically Unstable Rare Fragile Sites and Determine Cancer Outcomes
Marquardt S, Richter C, Pützer BM, Logotheti SPlacenta. 2020 Jan 15;90:109-117. doi: 10.1016/j.placenta.2019.12.018. Epub 2019 Dec 24.